Thus the pleiotropic effects of PPARG and its ligands/agonists on cellular metabolism during infection suggest that modulation of PPARG expression (and its ligands/agonists) alone or the interaction between MR and PPARG can be utilized as a promising host-directed therapy tool in the control of intracellular mycobacteria as well as disease progression. This evidence concerns the gene PPARG and infection.